The effect of simvastatin treatment on the amyloid precursor protein and brain cholesterol metabolism in patients with Alzheimer's disease.
about
Possible modification of Alzheimer's disease by statins in midlife: interactions with genetic and non-genetic risk factorsMolecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics.The effects of cholesterol on learning and memory.ACAT inhibition and amyloid beta reduction.Therapy for Alzheimer's Disease: How Effective are Current Treatments?Roles of cholesterol and lipids in the etiopathogenesis of Alzheimer's disease.Cholesterol and 24S-hydroxycholesterol trafficking in Alzheimer's disease.Statin-associated pleiotropy: possible beneficial effects beyond cholesterol reduction.Effect of statins on beta-amyloid metabolism in humans: potential importance for the development of senile plaques in Alzheimer's disease.Can statins put the brakes on Alzheimer's disease?Effects of simvastatin on cholesterol metabolism and Alzheimer disease biomarkers.Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease.Long-term benefits after treatment of traumatic brain injury with simvastatin in rats.Intracellular cholesterol homeostasis and amyloid precursor protein processing.Amyloid-modifying therapies for Alzheimer's disease: therapeutic progress and its implications.Novel disease-modifying therapeutics for the treatment of Alzheimer's disease.Cognitive effects of statin medications.Lovastatin Differentially Affects Neuronal Cholesterol and Amyloid-β Production in vivo and in vitro.Lovastatin inhibits formation of AA amyloid.Cerebrospinal fluid levels of soluble amyloid precursor protein and β-amyloid 42 in patients with multiple sclerosis, neuromyelitis optica and clinically isolated syndrome.Simvastatin inhibits the apoptosis of hippocampal cells in a mouse model of Alzheimer's disease.
P2860
Q30814231-22C53CC8-1FEB-4EBD-93BF-0DE2330BAD6CQ31047131-A4CECB1B-217E-4087-AA29-368886EED8B3Q33976829-9D103C52-527D-41C3-80D1-C6FA0404EF22Q34052308-D635C66C-E2F7-485E-8D23-17D997301900Q34409349-0F169DF4-74B8-401B-8ABA-84C76C3D8A5EQ35016920-69615599-682B-466D-8523-5F0094649DADQ36492343-2132522B-1769-4F0F-B6F6-8455CE1D0CB1Q36520623-7E8530E3-36BC-467D-82EF-D8CC58B61FA1Q36546521-316DEE6B-8D1A-404E-B1A6-4D1359CCEEF9Q36654316-084EC2B4-8552-4C2C-AC5B-12BC358D84F4Q36959256-17452AF7-2998-4A5D-A501-D32178EAD541Q37068847-78E6946B-AA38-4BC7-93E2-3D074E3B8476Q37341566-ADCA5E50-7CEB-49EE-B3CE-151B6FCD22E9Q37715386-65CF49A0-474E-4833-A486-4C35997C9F99Q37773826-2A71BBE7-4A56-4375-82CC-063E948731EEQ38127470-B9755BAE-4DAC-4B49-A50F-3629AAC42485Q38185988-E460944E-9698-40F6-A60F-D53F11A3D240Q38861519-23A8A61E-4A3F-4FC6-9EF5-3ED8AF3179C6Q40426715-1576C628-9D26-4953-A64B-EF89CD04A698Q48684415-1DF05931-10D4-4FA7-83FC-A68AA3E2A230Q49747183-5541DC72-F65D-4F20-AA44-49FF0F5B4EEC
P2860
The effect of simvastatin treatment on the amyloid precursor protein and brain cholesterol metabolism in patients with Alzheimer's disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
The effect of simvastatin trea ...... ents with Alzheimer's disease.
@en
The effect of simvastatin trea ...... ents with Alzheimer's disease.
@nl
type
label
The effect of simvastatin trea ...... ents with Alzheimer's disease.
@en
The effect of simvastatin trea ...... ents with Alzheimer's disease.
@nl
prefLabel
The effect of simvastatin trea ...... ents with Alzheimer's disease.
@en
The effect of simvastatin trea ...... ents with Alzheimer's disease.
@nl
P2093
P2860
P50
P356
P1476
The effect of simvastatin trea ...... ents with Alzheimer's disease.
@en
P2093
Lutjohann D
Syversen S
Vanderstichele H
von Bergmann K
P2860
P304
P356
10.1159/000084550
P577
2005-03-21T00:00:00Z